Skip to main content
. Author manuscript; available in PMC: 2021 Feb 17.
Published in final edited form as: Int J Cardiol. 2019 Sep 6;301:135–141. doi: 10.1016/j.ijcard.2019.09.004

Table 1.

Effects of Ang-(1–12) on Steady-State Hemodynamics in Normal and after HF

Control (n=10) HF (n=16)


Baseline Ang-(1–12) Baseline Ang-(1–12)

Heart rate (beats/min) 254±36 255±35 250 ± 24 248±24
Stroke Volume (μl) 169.0±17.6 228.1±16.0 121.5 ± 21.9 * 93.2±21.6
Ejection Fraction (%) 60±3 65±3 31 ± 5* 23±5
LV end-diastolic pressure (mm Hg) 5.5±1.1 6.0±0.7 14.2 ± 1.6 * 18.3±1.2
LV end-systolic pressure (mm Hg) 101±6 144±6 107 ± 5 145±13
LV end-diastolic volume (μl) 320.9±23.8 335.1±21.4 394.1 ± 17.5* 402.0±19.4
LV end-systolic volume (μl) 151.9±28.5 106.9±19.8 272.6 ± 16.6 * 308.9±12.6
Maximum dV/dt (μl /sec) 6,954±864 6,929±730 4,683 ± 335 * 3,547±268
Time constant of relaxation (msec) 9.7±0.6 9.6±0.7 16.0 ± 2.4 * 23.0±2.7
EA (mm Hg/μl) 0.60±0.06 0.63±0.04 0.91 ± 0.15 * 1.63±0.34

Values are means ± SD. n= number of rats.

LV, left ventricular; maximum dV/dt, the peak rate of mitral flow; EA, arterial elastance.

*

P <0.05, HF baseline vs. control baseline.

P <0.05, Ang-(1–12) vs. corresponding baseline value.

p<0.05, Ang-(1–12)-induced changes after HF vs. Ang-(1–12)-induced changes in normal.